184 related articles for article (PubMed ID: 1915443)
1. Dilated cardiomyopathy and myocarditis: monoclonal antibodies to diseased heart tissues.
Spry CJ; Tai PC
Eur Heart J; 1991 Aug; 12 Suppl D():130-3. PubMed ID: 1915443
[TBL] [Abstract][Full Text] [Related]
2. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance.
Caforio AL; Mahon NJ; Tona F; McKenna WJ
Eur J Heart Fail; 2002 Aug; 4(4):411-7. PubMed ID: 12167378
[TBL] [Abstract][Full Text] [Related]
3. [Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy].
Lauer B; Padberg K; Schultheiss HP; Strauer BE
Z Kardiol; 1995 Apr; 84(4):301-10. PubMed ID: 7785303
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
[TBL] [Abstract][Full Text] [Related]
5. Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives.
Caforio AL; Goldman JH; Haven AJ; Baig KM; McKenna WJ
Int J Cardiol; 1996 May; 54(2):157-63. PubMed ID: 8803680
[TBL] [Abstract][Full Text] [Related]
6. Anti-heart autoantibodies in familial dilated cardiomyopathy.
Caforio AL; Vinci A; Iliceto S
Autoimmunity; 2008 Sep; 41(6):462-9. PubMed ID: 18781472
[TBL] [Abstract][Full Text] [Related]
7. The possible value of synthetic peptides in the diagnosis and therapy of myocarditis and dilated cardiomyopathy.
Schwimmbeck PL; Bland NK; Schultheiss HP; Strauer BE
Eur Heart J; 1991 Aug; 12 Suppl D():76-80. PubMed ID: 1717275
[TBL] [Abstract][Full Text] [Related]
8. Abnormal expression of histocompatibility and mitochondrial antigens by cardiac tissue from patients with myocarditis and dilated cardiomyopathy.
Ansari AA; Wang YC; Danner DJ; Gravanis MB; Mayne A; Neckelmann N; Sell KW; Herskowitz A
Am J Pathol; 1991 Aug; 139(2):337-54. PubMed ID: 1867322
[TBL] [Abstract][Full Text] [Related]
9. Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy.
Caforio AL; Mahon NJ; Mckenna WJ
Autoimmunity; 2001; 34(3):199-204. PubMed ID: 11908778
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance and pathogenic role of anti-cardiac myosin autoantibody in dilated cardiomyopathy.
Wang Z; Liao Y; Dong J; Li S; Wang J; Fu ML
Chin Med J (Engl); 2003 Apr; 116(4):499-502. PubMed ID: 12875710
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory dilated cardiomyopathy (DCMI).
Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
[TBL] [Abstract][Full Text] [Related]
12. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy.
Caforio AL; Bauce B; Boffa GM; De Cian F; Angelini A; Melacini P; Razzolini R; Fasoli G; Chioin R; Schiaffino S; Thiene G; Dalla Volta S
G Ital Cardiol; 1997 Feb; 27(2):106-12. PubMed ID: 9199945
[TBL] [Abstract][Full Text] [Related]
13. Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy.
Caforio AL; Grazzini M; Mann JM; Keeling PJ; Bottazzo GF; McKenna WJ; Schiaffino S
Circulation; 1992 May; 85(5):1734-42. PubMed ID: 1533350
[TBL] [Abstract][Full Text] [Related]
14. [Idiopathic dilated cardiomyopathy: a persistent viral infection or an organ-specific autoimmune disease? The trial of 2 major pathogenetic hypotheses].
Caforio AL; Bonifacio E; Keeling PJ; Grazzini M; Schiaffino S; Bottazzo GF; McKenna WJ
G Ital Cardiol; 1992 Jan; 22(1):63-72. PubMed ID: 1624070
[TBL] [Abstract][Full Text] [Related]
15. HLA-DQB1* polymorphism and associations with dilated cardiomyopathy, inflammatory dilated cardiomyopathy and myocarditis.
Portig I; Sandmoeller A; Kreilinger S; Maisch B
Autoimmunity; 2009 Jan; 42(1):33-40. PubMed ID: 19127454
[TBL] [Abstract][Full Text] [Related]
16. Auto-antibody against adenine nucleotide translocator in dilated cardiomyopathy and myocarditis--incidence and relation to cardiac function and morphology.
Takemoto M; Kusachi S; Urabe N; Inoue K; Tsuji T
Jpn Circ J; 1993 Dec; 57(12):1150-8. PubMed ID: 8283607
[TBL] [Abstract][Full Text] [Related]
17. Presence and significance of some antibodies/autoantibodies in patients with acute myocardial infarction and idiopathic dilated cardiomyopathy.
Matache C; Stefănescu M; Ivanov D; Szegli G; Popescu P; Filip Z
Roum Arch Microbiol Immunol; 1992; 51(4):197-203. PubMed ID: 1284800
[TBL] [Abstract][Full Text] [Related]
18. [Expression of contractile and cytoskeletal proteins in myocardium of patients with dilated cardiomyopathy.].
Branishte TA; Dudnakova TV; Dergilev KV; Severin VV; Naumov VG; Shirinskiĭ VP; Belenkov IuN
Kardiologiia; 2004; 44(12):31-6. PubMed ID: 15699919
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of anti-cardiac immunity in dilated cardiomyopathy.
Caforio AL; Mahon NG; McKenna WJ
Ernst Schering Res Found Workshop; 2006; (55):169-93. PubMed ID: 16329663
[TBL] [Abstract][Full Text] [Related]
20. Genetically determined myocarditis: clinical presentation and immunological characteristics.
Caforio AL; Iliceto S
Curr Opin Cardiol; 2008 May; 23(3):219-26. PubMed ID: 18382209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
